Theravance Biopharma Inc TBPH:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/04/21 EST
18.76quote price arrow down-0.16 (-0.85%)
Volume
291,194
52 week range
14.48 - 31.35

...

Loading . . .

KEY STATS

  • Open18.84
  • Day High19.20
  • Day Low18.33
  • Prev Close18.76
  • 52 Week High31.35
  • 52 Week High Date04/29/20
  • 52 Week Low14.48
  • 52 Week Low Date10/01/20
  • Market Cap1.207B
  • Shares Out64.33M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta0.85
  • 1 Year % Change-28.1

RATIOS/PROFITABILITY

  • EPS (TTM)-4.48
  • P/E (TTM)-4.19
  • Fwd P/E (NTM)-5.20
  • EBITDA (MRQ)-290.959M
  • ROE (MRQ)-677.87%
  • Revenue (MRQ)71.86M
  • Gross Margin (MRQ)26.07%
  • Net Margin (MRQ)-386.90%
  • Debt To Equity (MRQ)-203.84%

EVENTS

  • Earnings Date05/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Theravance Biopharma Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Theravance Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company's pipeline of internally discovered product candidates includes medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. Its commercial...
Rick Winningham
Chairman
Andrew Hindman
Chief Financial Officer
Bradford Shafer Esq. J.D.
Executive Vice President
Address
UGLAND HOUSE, SOUTH CHURCH STREET
George Town
KY1-1104
Cayman Islands